Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics. Read more about Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics.
Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial. Read more about Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial.
Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial. Read more about Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial.
Minimum information about clinical artificial intelligence modeling: the MI-CLAIM checklist. Read more about Minimum information about clinical artificial intelligence modeling: the MI-CLAIM checklist.
The role of exome sequencing in newborn screening for inborn errors of metabolism. Read more about The role of exome sequencing in newborn screening for inborn errors of metabolism.
Systemic dysfunction and plasticity of the immune macroenvironment in cancer models. Read more about Systemic dysfunction and plasticity of the immune macroenvironment in cancer models.
Effects of underfeeding and oral vancomycin on gut microbiome and nutrient absorption in humans. Read more about Effects of underfeeding and oral vancomycin on gut microbiome and nutrient absorption in humans.
Viable bacterial colonization is highly limited in the human intestine in utero. Read more about Viable bacterial colonization is highly limited in the human intestine in utero.
Near real-time intraoperative brain tumor diagnosis using stimulated Raman histology and deep neural networks. Read more about Near real-time intraoperative brain tumor diagnosis using stimulated Raman histology and deep neural networks.
Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma. Read more about Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma.
